Good Bowls: Eat Well At Work

Summary

The goal of this clinical trial is to improve the health of workers at their worksite by providing subsidized healthy meals supported by nutrition education and behavioral nudges using mobile health and Bluetooth technology.

The aim of this study is to:

Randomize 240 individuals in 8-10 worksites to either Good Bowls alone or Good Bowls + Phone App nudges. Using a crossover design, the primary outcome is the score on a validated Mediterranean diet screener, with secondary outcomes including weight, blood pressure, carotenoid levels, and food security.

Participants: Workers at blue and white-collar worksites.

Procedures: Workers will be recruited from 8-10 worksites who will be initially randomized within each site to Good Bowls alone or Good Bowls + Phone App nudges. Initial assignment will be followed for four months, after which the groups will crossover for the subsequent four months. The investigators will collect survey data as well as some physiologic measures including skin scanning (non-invasive), weight, and blood pressure. Effects between groups will be determined.

Conditions

• Nutrition, Healthy
• Behavior, Eating

Interventions

BEHAVIORAL

Good Bowls

Healthy, frozen subsidized meals are made conveniently available on worksites.

BEHAVIORAL

Good Bowls + App Nudges

Healthy, frozen subsidized meals are made conveniently available on worksites. Additionally, Bluetooth enabled beacons will be set up at each worksite that will send location specific messages to an individual's Smartphone via an App. These messages will include nutritional information, tips, and behavioral nudges.

Sponsors & Collaborators

• National Institutes of Health (NIH)

  collaborator NIH

• University of North Carolina, Chapel Hill

  collaborator OTHER

• University of North Carolina, Greensboro

  collaborator OTHER

• North Carolina State University

  collaborator OTHER

• Equiti Food, LLC

  lead INDUSTRY

Principal Investigators

• Kurt Ribisl, PhD · University of North Carolina, Chapel Hill

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Model

CROSSOVER

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2023-03-15

Primary Completion

2025-07-21

Completion

2025-07-31

Countries

• United States

Study Locations